March 2019 - Page 21 of 61 - NetworkNewsWire

TuesdayMar 19, 2019 2:30 pm

Semtech Corp. (NASDAQ: SMTC) Attends 31st Annual ROTH Conference

Semtech (NASDAQ: SMTC) is a supplier of high-performance analog and mixed-signal semiconductors and advanced algorithms for high-end consumer, enterprise computing, communications, and industrial equipment. Products are designed to benefit the engineering community as well as the global community. The company is dedicated to reducing its impact on the environment. Internal green programs seek to reduce waste through material and manufacturing control, use of green technology and designing for resource reduction. For more information, visit the company's website at www.semtech.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire…

TuesdayMar 19, 2019 2:30 pm

Sellas Life Sciences Group Inc. (NASDAQ: SLS) Attends 31st Annual ROTH Conference

Sellas Life Sciences Group (NASDAQ: SLS) is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. SELLAS’ lead product candidate, galinpepimut-S (GPS), is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 (WT1) protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination to address a broad spectrum of hematologic malignancies and solid tumor indications. SELLAS has a phase 3 clinical trial planned (pending funding availability) for GPS in acute myeloid leukemia (AML) and is also studying GPS in combination…

TuesdayMar 19, 2019 2:30 pm

Second Sight Medical Products Inc. (NASDAQ: EYES) Attends 31st Annual ROTH Conference

Second Sight Medical Products (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics intended to deliver useful artificial vision to blind individuals. A global leader in neuromodulation devices for blindness, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus® II Retinal Prosthesis System is the only FDA and CE Mark approved device for treating retinitis pigmentosa, with proven implant durability of multiple years. The company is developing the Orion® Visual Cortical Prosthesis which is intended to provide useful artificial vision to individuals who are blind due to various causes. For…

TuesdayMar 19, 2019 2:30 pm

Seabridge Gold Inc. (NYSE: SA) Attends 31st Annual ROTH Conference

Seabridge Gold (NYSE: SA) is designed to provide shareholders with exceptional leverage to a rising gold price. From 1999 through 2002, when the gold price was lower, Seabridge acquired nine North American projects with substantial gold resources. Seabridge is pursuing three value-enhancing strategies. First, the company continues to search for accretive gold projects in North America. Second, Seabridge funds exploration and engineering work considered likely to expand resources and upgrade them to reserves. Third, Seabridge sells or partners its projects when they reach the production stage, to limit risk and share dilution. For more information, visit the company's website at…

TuesdayMar 19, 2019 2:00 pm

Denison Mines Corp. (NYSE American: DNN) Attends 31st Annual ROTH Conference

Denison Mines (NYSE American: DNN) is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. In addition to its 90% owned Wheeler River project, Denison's Athabasca Basin exploration portfolio consists of numerous projects covering approximately 320,000 hectares. Denison's interests also include a 22.5% ownership interest in the McClean Lake joint venture, which is currently processing ore from the Cigar Lake mine under a toll milling agreement, plus a 25.17% interest in the Midwest and Midwest A deposits, and a 65.92% interest in the J Zone and Huskie deposits on the Waterbury…

TuesdayMar 19, 2019 2:00 pm

Delta Apparel Inc. (NYSE American: DLA) Attends 31st Annual ROTH Conference

Delta Apparel (NYSE American: DLA) along with its operating subsidiaries, Salt Life LLC, M. J. Soffe LLC, and DTG2Go LLC, is an international design, marketing, manufacturing and sourcing company that features a diverse portfolio of lifestyle basic and branded activewear apparel, headwear and related accessories. The company specializes in selling casual and athletic products across distribution tiers, including specialty stores, boutiques, department stores, mid-tier and mass chains, and the U.S. military. The company’s products are also made available direct-to-consumer on its websites (www.saltlife.com, www.coastapparel.com, www.soffe.com and www.deltaapparel.com). For more information, visit the company's website at www.deltaapparelinc.com. About NetworkNewsWire NetworkNewsWire (NNW)…

TuesdayMar 19, 2019 2:00 pm

S&W Seed Company (NASDAQ: SANW) Attends 31st Annual ROTH Conference

S&W Seed Company (NASDAQ: SANW) is a global agricultural company headquartered in Sacramento, California. S&W’s vision is to be the world’s preferred proprietary seed company supplying a range of forage and specialty crop products that supports the growing global demand for animal proteins and healthier consumer diets. S&W is a global leader in alfalfa seed and sorghum hybrid, with significant research and development, production and distribution capabilities. S&W also provides hybrid sunflower and is utilizing its research and breeding expertise to develop and produce stevia, the all-natural, zero calorie sweetener for the food and beverage industry. For more information, visit…

TuesdayMar 19, 2019 2:00 pm

Daxor Corp. (NYSE American: DXR) Attends 31st Annual ROTH Conference

Daxor (NYSE American: DXR) is an innovative medical instrumentation and biotechnology company that manufactures the BVA-100 Blood Volume Analyzer, the only clinically available, rapid and accurate diagnostic to provide rapid direct measurement of a patient’s blood volume. Daxor believes that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. The company’s goal, working in conjunction with hospitals and clinics, is to achieve that possibility. Ultimately the company’s mission is to help hospitals and physicians incorporate Daxor’s BVA-100 diagnostic to significantly improve the quality of patient care. For more information,…

TuesdayMar 19, 2019 2:00 pm

Rosetta Stone Inc. (NYSE: RST) Attends 31st Annual ROTH Conference

Rosetta Stone (NYSE: RST) is dedicated to changing people's lives through the power of language and literacy education. The company's innovative digital solutions drive positive learning outcomes for the inspired learner at home or in schools and workplaces around the world. Rosetta Stone's language division uses cloud-based solutions to help all types of learners read, write and speak more than 30 languages. Lexia Learning, Rosetta Stone's literacy education division is a leader in the literacy education space and helps students build fundamental reading skills through its rigorously researched, independently evaluated, and widely respected instruction and assessment programs. For more information,…

TuesdayMar 19, 2019 2:00 pm

Ritter Pharmaceuticals Inc. (NASDAQ: RTTR) Attends 31st Annual ROTH Conference

Ritter Pharmaceuticals (NASDAQ: RTTR) develops innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. The company’s lead product candidate, RP-G28, has the potential to become the first FDA-approved treatment for lactose intolerance, a condition that affects millions worldwide. RP-G28 is in phase 3 clinical development with its first phase 3 clinical trial, known as “Liberatus,” currently underway. The company is further exploring the therapeutic potential that gut microbiome changes may have on treating/preventing a variety of diseases including gastrointestinal diseases, cancer, metabolic, and liver disease. For more information, visit the company's website at www.RitterPharma.com. About NetworkNewsWire NetworkNewsWire…